Passa al contenuto
Merck
  • Antigen targeting to dendritic cells combined with transient regulatory T cell inhibition results in long-term tumor regression.

Antigen targeting to dendritic cells combined with transient regulatory T cell inhibition results in long-term tumor regression.

Oncoimmunology (2015-09-26)
Wendy Wj Unger, Christian T Mayer, Steef Engels, Christina Hesse, Maurizio Perdicchio, Franz Puttur, Ingeborg Streng-Ouwehand, Manja Litjens, Hakan Kalay, Luciana Berod, Tim Sparwasser, Yvette van Kooyk
PMID26405564
ABSTRACT

Therapeutic vaccinations against cancer are still largely ineffective. Major caveats are inefficient delivery of tumor antigens to dendritic cells (DCs) and excessive immune suppression by

MATERIALI
Numero di prodotto
Marchio
Descrizione del prodotto
I9516
Sigma-Aldrich
2-Propanolo, BioReagent, ≥99.5%, Molecular Biology
P8139
Sigma-Aldrich
Forbolo 12-miristato 13-acetato, ≥99% (TLC), film or powder
D9542
Sigma-Aldrich
DAPI, for nucleic acid staining
P1585
Sigma-Aldrich
PMA, for use in molecular biology applications, ≥99% (HPLC), Molecular Biology
278475
Sigma-Aldrich
2-Propanolo, anhydrous, 99.5%
W292907
Sigma-Aldrich
2-Propanolo, ≥99.7%, FCC, FG
59304
Sigma-Aldrich
2-Propanolo, BioUltra, Molecular Biology, ≥99.5% (GC)
B7651
Sigma-Aldrich
Brefeldina A, from Penicillium brefeldianum, ≥99% (HPLC and TLC)
B6542
Sigma-Aldrich
Brefeldina A, ≥99% (HPLC and TLC), BioXtra, Molecular Biology
733458
Sigma-Aldrich
2-Propanolo, electronic grade, 99.999% trace metals basis
79346
Sigma-Aldrich
Forbolo 12-miristato 13-acetato, synthetic, ≥98.0% (TLC)
B5936
Sigma-Aldrich
Brefeldina A, Ready Made Solution, from Penicillium brefeldianum, 10 mg/mL in DMSO
675431
Sigma-Aldrich
2-Propanolo, HPLC Plus, for HPLC, GC, and residue analysis, 99.9%, poly coated bottles
E2028
Sigma-Aldrich
Ethidium bromide monoazide, ≥95% (HPLC), solid